Approval · Notice of Compliance 11867 · 2010
VITAROS: Notice of Compliance 11867
Issued November 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11867
- Date
- November 12, 2010
- Company
- Nexmed Usa IncSan Diego, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Treatment of male erectile dysfunction
Products in this notice
Medicinal ingredients
- ALPROSTADIL 220 MCG per 100MG
- ALPROSTADIL 330 MCG per 100MG